Breast cancer: evaluation of response to neoadjuvant chemotherapy with 3.0-T MR imaging
JH Chen, S Bahri, RS Mehta, A Kuzucan, HJ Yu… - Radiology, 2011 - pubs.rsna.org
Purpose To assess how the molecular biomarker status of a breast cancer, including human
epidermal growth factor receptor 2 (HER2), hormone receptors, and the proliferation marker …
epidermal growth factor receptor 2 (HER2), hormone receptors, and the proliferation marker …
[引用][C] Breast Cancer: Evaluation of Response to Neoadjuvant Chemotherapy with 3, 0-T MR Imaging
JH CHEN, S BAHRI, JA BUTLER, O NALCIOGLU… - …, 2011 - pascal-francis.inist.fr
Breast Cancer: Evaluation of Response to Neoadjuvant Chemotherapy with 3,0-T MR Imaging
CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple search …
CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple search …
[PDF][PDF] Breast Cancer: Evaluation of Response to Neoadjuvant Chemotherapy with 3.0-T MR Imaging
JH Chen, S Bahri, RS Mehta, A Kuzucan, JY Hon… - …, 2011 - researchgate.net
Breast Cancer: Evaluation of Response to Neoadjuvant Chemotherapy with 3.0-T MR
Imaging 1 Page 1 Note: This copy is for your personal, non-commercial use only. To order …
Imaging 1 Page 1 Note: This copy is for your personal, non-commercial use only. To order …
[引用][C] Breast Cancer: Evaluation of Response to Neoadjuvant Chemotherapy with 3.0-T MR Imaging
JH Chen, S Bahri, RS Mehta, A Kuzucan, HJ Yu… - Radiology, 2011 - cir.nii.ac.jp
Breast Cancer: Evaluation of Response to Neoadjuvant Chemotherapy with 3.0-T MR Imaging |
CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ …
CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ …
[PDF][PDF] Breast Cancer: Evaluation of Response to Neoadjuvant Chemotherapy with 3.0-T MR Imaging
JH Chen, S Bahri, RS Mehta, A Kuzucan, JY Hon… - Radiology, 2011 - academia.edu
Breast Cancer: Evaluation of Response to Neoadjuvant Chemotherapy with 3.0-T MR
Imaging 1 Page 1 Note: This copy is for your personal, non-commercial use only. To order …
Imaging 1 Page 1 Note: This copy is for your personal, non-commercial use only. To order …
Breast Cancer: Evaluation of Response to Neoadjuvant Chemotherapy with 3.0-T MR Imaging
JH Chen, S Bahri, RS Mehta, A Kuzucan, JY Hon… - Radiology, 2011 - pubs.rsna.org
Purpose To assess how the molecular biomarker status of a breast cancer, including human
epidermal growth factor receptor 2 (HER2), hormone receptors, and the proliferation marker …
epidermal growth factor receptor 2 (HER2), hormone receptors, and the proliferation marker …
[HTML][HTML] Breast Cancer: Evaluation of Response to Neoadjuvant Chemotherapy with 3.0-T MR Imaging
JH Chen, S Bahri, RS Mehta, A Kuzucan, JY Hon… - Radiology, 2011 - ncbi.nlm.nih.gov
Purpose: To assess how the molecular biomarker status of a breast cancer, including human
epidermal growth factor receptor 2 (HER2), hormone receptors, and the proliferation marker …
epidermal growth factor receptor 2 (HER2), hormone receptors, and the proliferation marker …
Breast cancer: evaluation of response to neoadjuvant chemotherapy with 3.0-T MR imaging.
JH Chen, S Bahri, RS Mehta, A Kuzucan, HJ Yu… - Radiology, 2011 - europepmc.org
Purpose To assess how the molecular biomarker status of a breast cancer, including human
epidermal growth factor receptor 2 (HER2), hormone receptors, and the proliferation marker …
epidermal growth factor receptor 2 (HER2), hormone receptors, and the proliferation marker …
Breast cancer: evaluation of response to neoadjuvant chemotherapy with 3.0-T MR imaging
JH Chen, S Bahri, RS Mehta, A Kuzucan… - …, 2011 - pubmed.ncbi.nlm.nih.gov
Purpose To assess how the molecular biomarker status of a breast cancer, including human
epidermal growth factor receptor 2 (HER2), hormone receptors, and the proliferation marker …
epidermal growth factor receptor 2 (HER2), hormone receptors, and the proliferation marker …
Breast cancer: evaluation of response to neoadjuvant chemotherapy with 3.0-T MR imaging.
JH Chen, S Bahri, RS Mehta, A Kuzucan, HJ Yu… - Radiology, 2011 - europepmc.org
Purpose To assess how the molecular biomarker status of a breast cancer, including human
epidermal growth factor receptor 2 (HER2), hormone receptors, and the proliferation marker …
epidermal growth factor receptor 2 (HER2), hormone receptors, and the proliferation marker …